A detailed history of Raymond James & Associates transactions in Agilon Health, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 12,563 shares of AGL stock, worth $38,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,563
Previous 12,687 0.98%
Holding current value
$38,819
Previous $82,000 40.24%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$3.21 - $7.52 $398 - $932
-124 Reduced 0.98%
12,563 $49,000
Q2 2024

Jul 19, 2024

SELL
$4.46 - $6.9 $2,368 - $3,663
-531 Reduced 4.02%
12,687 $82,000
Q1 2024

Apr 22, 2024

SELL
$4.76 - $12.93 $6,925 - $18,813
-1,455 Reduced 9.92%
13,218 $80,000
Q4 2023

Jan 16, 2024

BUY
$10.62 - $19.8 $155,827 - $290,525
14,673 New
14,673 $184,000

Others Institutions Holding AGL

About agilon health, inc.


  • Ticker AGL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 410,936,000
  • Market Cap $1.27B
  • Description
  • agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon ...
More about AGL
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.